Statistics
Publications
7
Citations
415
H-Index
7
Active since
2011
Min Thura is an author at Institute of Molecular and Cell Biology specializing in oncology, medicine, and cancer progression.
Publications per year
2011–2023
7
7
PRL3-zumab, a first-in-class humanized antibody for cancer therapy
Min Thura, Abdul Qader Al-Aidaroos, Wei Peng Yong et al. · JCI Insight · 2016 · 58 citations · Full text
Medicine, Oncology, Pharmacology +17
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
Min Thura, Abdul Qader Al-Aidaroos, Abhishek Gupta et al. · Nature Communications · 2019 · 48 citations · Full text
Life Sciences, Immunology, Oncology +17
PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
Min Thura, Zu Ye, Abdul Qader Al-Aidaroos et al. · Communications Biology · 2021 · 28 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 7